| Baseline susceptibility of primary HIV-2 to entry inhibitors P Borrego, R Calado, JM Marcelino, I Bártolo, C Rocha, P Cavaco-Silva, ... Antiviral therapy 17 (3), 565-570, 2012 | 63 | 2012 |
| Evolutionary and structural features of the C2, V3 and C3 envelope regions underlying the differences in HIV-1 and HIV-2 biology and infection H Barroso, P Borrego, I Bártolo, JM Marcelino, C Família, A Quintas, ... PloS one 6 (1), e14548, 2011 | 47 | 2011 |
| Hospital resource utilization and treatment cost of skeletal-related events in patients with metastatic breast or prostate cancer: estimation for the Portuguese National Health … J Felix, V Andreozzi, M Soares, P Borrego, H Gervasio, A Moreira, L Costa, ... Value in Health 14 (4), 499-505, 2011 | 43 | 2011 |
| A helical short-peptide fusion inhibitor with highly potent activity against human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus S Xiong, P Borrego, X Ding, Y Zhu, A Martins, H Chong, N Taveira, Y He Journal of virology 91 (1), 10.1128/jvi. 01839-16, 2017 | 39 | 2017 |
| An ancestral HIV-2/simian immunodeficiency virus peptide with potent HIV-1 and HIV-2 fusion inhibitor activity P Borrego, R Calado, JM Marcelino, P Pereira, A Quintas, H Barroso, ... Aids 27 (7), 1081-1090, 2013 | 37 | 2013 |
| Origin and epidemiological history of HIV-1 CRF14_BG I Bartolo, AB Abecasis, P Borrego, H Barroso, F McCutchan, P Gomes, ... PLoS One 6 (9), e24130, 2011 | 36 | 2011 |
| Potent and broadly reactive HIV-2 neutralizing antibodies elicited by a vaccinia virus vector prime-C2V3C3 polypeptide boost immunization strategy JM Marcelino, P Borrego, C Rocha, H Barroso, A Quintas, C Novo, ... Journal of virology 84 (23), 12429-12436, 2010 | 36 | 2010 |
| Development of water-soluble polyanionic carbosilane dendrimers as novel and highly potent topical anti-HIV-2 microbicides V Briz, D Sepúlveda-Crespo, AR Diniz, P Borrego, B Rodes, ... Nanoscale 7 (35), 14669-14683, 2015 | 35 | 2015 |
| Resistance to antibody neutralization in HIV-2 infection occurs in late stage disease and is associated with X4 tropism JM Marcelino, P Borrego, C Nilsson, C Família, H Barroso, F Maltez, ... Aids 26 (18), 2275-2284, 2012 | 35 | 2012 |
| The role of the humoral immune response in the molecular evolution of the envelope C2, V3 and C3 regions in chronically HIV-2 infected patients P Borrego, JM Marcelino, C Rocha, M Doroana, F Antunes, F Maltez, ... Retrovirology 5 (1), 1-12, 2008 | 32 | 2008 |
| HIV-2 genetic evolution in patients with advanced disease is faster than that in matched HIV-1 patients H Skar, P Borrego, TC Wallstrom, M Mild, JM Marcelino, H Barroso, ... Journal of virology 84 (14), 7412-7415, 2010 | 30 | 2010 |
| Epidemic history of hepatitis C virus genotypes and subtypes in Portugal C Palladino, IJ Ezeonwumelu, R Marcelino, V Briz, I Moranguinho, ... Scientific reports 8 (1), 12266, 2018 | 27 | 2018 |
| Evolution of the human immunodeficiency virus type 2 envelope in the first years of infection is associated with the dynamics of the neutralizing antibody response C Rocha, R Calado, P Borrego, JM Marcelino, I Bártolo, L Rosado, ... Retrovirology 10, 1-14, 2013 | 25 | 2013 |
| Antagonism of BST-2/tetherin is a conserved function of the Env glycoprotein of primary HIV-2 isolates CY Chen, M Shingai, S Welbourn, MA Martin, P Borrego, N Taveira, ... Journal of virology 90 (24), 11062-11074, 2016 | 23 | 2016 |
| Envelope-specific antibody response in HIV-2 infection: C2V3C3-specific IgG response is associated with disease progression JM Marcelino, C Nilsson, H Barroso, P Gomes, P Borrego, F Maltez, ... Aids 22 (17), 2257-2265, 2008 | 21 | 2008 |
| Diagnosis of sleep apnea in patients with stable chronic heart failure using a portable sleep test diagnostic device I Araújo, F Marques, S André, M Araújo, S Marques, R Ferreira, P Moniz, ... Sleep and Breathing 22, 749-755, 2018 | 18 | 2018 |
| A genotypic method for determining HIV-2 coreceptor usage enables epidemiological studies and clinical decision support M Döring, P Borrego, J Büch, A Martins, G Friedrich, RJ Camacho, ... Retrovirology 13 (1), 1-16, 2016 | 16 | 2016 |
| Rare HIV-1 subtype J genomes and a new H/U/CRF02_AG recombinant genome suggests an ancient origin of HIV-1 in Angola I Bártolo, R Calado, P Borrego, T Leitner, N Taveira AIDS research and human retroviruses 32 (8), 822-828, 2016 | 16 | 2016 |
| HIV-2 susceptibility to entry inhibitors. P Borrego, N Taveira AIDS reviews 15 (1), 49-61, 2013 | 16 | 2013 |
| Development of synthetic light-chain antibodies as novel and potent HIV fusion inhibitors C Cunha-Santos, TN Figueira, P Borrego, SS Oliveira, C Rocha, A Couto, ... Aids 30 (11), 1691-1701, 2016 | 15 | 2016 |
